Targeting the SOST-LRRC15 Axis Suppresses Triple-Negative Breast Cancer Progression in Laboratory Models
Researchers have identified a regulatory axis in triple-negative breast cancer where P300 acetylates sclerostin to facilitate its interaction with LRRC15, ...










